Mice transgenic for both TRE-MYC[24] and LAP-tTA[25] have been developed as a mouse model for hepatocellular carcinoma in which the human C-MYC transcription factor is expressed in the liver when doxycycline is absent [26]. This evidence concerns the gene MYC and hepatocellular carcinoma.